Vancomycin activators are a group of chemical compounds that play a pivotal role in enhancing the activity of the antibiotic vancomycin, a potent glycopeptide antibiotic primarily used to eliminate bacterial infections. These activators are a subgroup of molecules designed to augment the effectiveness of vancomycin in combating bacterial pathogens. The primary function of vancomycin activators lies in their ability to modulate the mechanism of action of vancomycin, which typically involves inhibiting bacterial cell wall synthesis. By interacting with vancomycin, these activators can augment its binding affinity to specific target sites on bacterial cell walls, thus promoting more effective disruption of the cell wall assembly process. In essence, they act as molecular assistants, enhancing the antibiotic's capacity to combat bacterial infections.
The chemical structure and composition of vancomycin activators vary, but their commonality lies in their capacity to interact with vancomycin molecules, leading to enhanced antibacterial activity. These activators are designed to bind to vancomycin without compromising its structural integrity, thereby facilitating a synergistic effect when combined with the antibiotic. They represent a promising avenue in the ongoing battle against antibiotic-resistant bacteria, as they offer a means to maximize the efficacy of existing antibiotics.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ampicillin | 69-53-4 | sc-210812 sc-210812A sc-210812B sc-210812C sc-210812D | 100 mg 1 g 5 g 25 g 100 g | $31.00 $101.00 $153.00 $115.00 $408.00 | 11 | |
This β-lactam antibiotic has been studied for its ability to induce vancomycin activator expression in some bacterial strains. It can work synergistically with vancomycin to combat infections. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Daptomycin is another antibiotic used against Gram-positive bacteria, and it may have a role in enhancing vancomycin's activity through an indirect mechanism. | ||||||
Bacitracin | 1405-87-4 | sc-252399 | 5 g | $89.00 | 1 | |
Bacitracin, an antibiotic produced by certain bacteria, has been investigated for its potential to induce vancomycin activator expression in laboratory settings. | ||||||
Clindamycin | 18323-44-9 | sc-337636A sc-337636B sc-337636C sc-337636 | 25 mg 50 mg 100 mg 1 g | $156.00 $374.00 $572.00 $825.00 | 2 | |
Clindamycin, a lincosamide antibiotic, has been examined for its impact on vancomycin activator expression, especially in cases of mixed bacterial infections. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampin is a potent antibiotic often used in combination with other antibiotics. It has been explored for its ability to induce vancomycin activator expression in some bacteria. | ||||||